These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 35251371)

  • 21. Metabolic Score for Insulin Resistance Is Inversely Related to Incident Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
    Lee JH; Kwon YJ; Park K; Lee HS; Park HK; Han JH; Ahn SB
    Nutrients; 2022 Jul; 14(15):. PubMed ID: 35893894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between METS-IR and heart failure: a cross-sectional study.
    Su X; Zhao C; Zhang X
    Front Endocrinol (Lausanne); 2024; 15():1416462. PubMed ID: 39015177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults.
    Sinn DH; Gwak GY; Park HN; Kim JE; Min YW; Kim KM; Kim YJ; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Am J Gastroenterol; 2012 Apr; 107(4):561-7. PubMed ID: 22108448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between the metabolic score for insulin resistance and prostate cancer: a cross-sectional study in Xinjiang.
    Wang J; Apizi A; Tao N; An H
    PeerJ; 2024; 12():e17827. PubMed ID: 39076779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated gamma-glutamyl transferase has a non-linear association with incident non-alcoholic fatty liver disease in the non-obese Chinese population: a secondary retrospective study.
    Wu L; Zhang M; Hu H; Wan Q
    Lipids Health Dis; 2021 Oct; 20(1):142. PubMed ID: 34689770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population.
    Zhang Y; Zhang T; Zhang C; Tang F; Zhong N; Li H; Song X; Lin H; Liu Y; Xue F
    BMJ Open; 2015 Sep; 5(9):e008204. PubMed ID: 26395497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
    Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
    J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A longitudinal epidemiological study on the triglyceride and glucose index and the incident nonalcoholic fatty liver disease.
    Zheng R; Du Z; Wang M; Mao Y; Mao W
    Lipids Health Dis; 2018 Nov; 17(1):262. PubMed ID: 30458848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Nonalcoholic Fatty Liver Disease in Familial Mediterranean Fever.
    Tasliyurt T; Gokce E; Sahin S; Aslan AB; Demir AK; Uzun S; Kutluturk F
    Endocr Metab Immune Disord Drug Targets; 2020; 20(6):952-958. PubMed ID: 32077835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between metabolic score for insulin resistance and regression to normoglycemia from prediabetes in Chinese adults: A retrospective cohort study.
    Liu XH; Xu Q; Zhang L; Liu HJ
    PLoS One; 2024; 19(8):e0308343. PubMed ID: 39110699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of noninvasive scoring systems for the prediction of nonalcoholic fatty liver disease in metabolic syndrome patients.
    Saokaew S; Kositamongkol C; Charatcharoenwitthaya P; Srivanichakorn W; Washirasaksiri C; Chaiyakunapruk N; Phisalprapa P
    Medicine (Baltimore); 2020 Dec; 99(50):e23619. PubMed ID: 33327335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factors for Nonalcoholic Fatty Liver Disease with Different Insulin Resistance in a Nonobese Chinese Population.
    Wu X; Wang Y; Jia Y; Liu J; Wang G
    J Diabetes Res; 2022; 2022():9060405. PubMed ID: 36568964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the longitudinal association between the GGT/HDL-C ratio and NAFLD: a cohort study in a non-obese Chinese population.
    Xie Q; Lu S; Kuang M; He S; Yu C; Hu C; Zou Y
    BMC Gastroenterol; 2022 Dec; 22(1):500. PubMed ID: 36471271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Harnessing Metabolic Indices as a Predictive Tool for Cardiovascular Disease in a Korean Population without Known Major Cardiovascular Event.
    Kim HJ; Kim BS; Lee Y; Ahn SB; Kim DW; Shin JH
    Diabetes Metab J; 2024 May; 48(3):449-462. PubMed ID: 38310879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The newly proposed Metabolic Score for Visceral Fat is a reliable tool for identifying non-alcoholic fatty liver disease, requiring attention to age-specific effects in both sexes.
    Kuang M; Qiu J; Li D; Hu C; Zhang S; Sheng G; Zou Y
    Front Endocrinol (Lausanne); 2023; 14():1281524. PubMed ID: 38089634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. METS-IR/HOMA-IR and MAFLD in U.S. adults: dose-response correlation and the effect mediated by physical activity.
    Peng H; Xiang J; Pan L; Zhao M; Chen B; Huang S; Yao Z; Liu J; Lv W
    BMC Endocr Disord; 2024 Aug; 24(1):132. PubMed ID: 39085855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the diagnostic performance of twelve noninvasive scores of metabolic dysfunction-associated fatty liver disease.
    Zou H; Ma X; Zhang F; Xie Y
    Lipids Health Dis; 2023 Sep; 22(1):145. PubMed ID: 37674196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men: 5-year's prospective cohort study.
    Ryoo JH; Choi JM; Moon SY; Suh YJ; Shin JY; Shin HC; Park SK
    Atherosclerosis; 2013 Apr; 227(2):398-403. PubMed ID: 23390894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive Value of Adiposity Level, Metabolic Syndrome, and Insulin Resistance for the Risk of Nonalcoholic Fatty Liver Disease Diagnosis in Obese Children.
    Prokopowicz Z; Malecka-Tendera E; Matusik P
    Can J Gastroenterol Hepatol; 2018; 2018():9465784. PubMed ID: 29854716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin Resistance and Non-Alcoholic Fatty Liver Disease in Premenopausal Women with Metabolic Syndrome.
    El-Sehrawy AA; State O; Elzehery RR; Mohamed AS
    Horm Metab Res; 2021 Feb; 53(2):100-104. PubMed ID: 33513642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.